Last updated: March 3, 2026
This analysis covers current market conditions, competitive landscape, regulatory status, and price projections for the drug identified by NDC 58151-0367.
Product Overview
NDC 58151-0367 is a prescription medication registered with the National Drug Code system. It is used for [specific indication], manufactured by [manufacturer name]. The formulation includes [active ingredient], with a strength of [strength], administered via [route]. Approved by the FDA on [approval date], it is indicated for [approved uses].
Market Landscape
Market Size and Demand
The market for drugs treating [therapeutic area] is expanding due to increased prevalence of [condition], with an estimated global market value of USD [value] as of 2022[1]. In the U.S., approximately [number] million patients have access to treatments within this space.
Competitive Environment
NDC 58151-0367 faces competition from:
| Product Name |
Manufacturer |
Indication |
Strength |
Price (USD per unit) |
Market Share (2022) |
| [Competitor A] |
[Name] |
[Indication] |
[mg] |
[Price] |
[Share]% |
| [Competitor B] |
[Name] |
[Indication] |
[mg] |
[Price] |
[Share]% |
| [NDC 58151-0367] |
[Manufacturer] |
[Indication] |
[mg] |
[Price] |
N/A (new entrant) |
Regulatory and Coverage Status
The drug has an FDA label. Medicare Part D and commercial insurers cover it depending on plan formulary tiers. As of 2023, coverage policies for this class have become more restrictive due to cost-control measures.
Pricing Trends and Projections
Historical Pricing
| Year |
Average Wholesale Price (AWP) |
Estimated Retail Price |
Notes |
| 2020 |
USD [value] |
USD [value] |
Initial launch |
| 2021 |
USD [value] |
USD [value] |
Slight increase (~X%) |
| 2022 |
USD [value] |
USD [value] |
Market stabilization |
Current Price Estimate
The current average retail price for NDC 58151-0367 is estimated at USD [amount] per treatment course. Wholesale acquisition cost (WAC) is approximately USD [amount]. The drug's pricing aligns with similar therapeutics in its class.
Future Price Projections
Based on market trends, regulatory influences, and competitive dynamics, future prices are projected to:
- 2024: stabilize around USD [amount], reflecting cost-control measures.
- 2025: potentially increase by 3-5% due to inflation and demand growth.
- 2026 and beyond: price volatility will be influenced by biosimilar entry, patent litigation, and formulary negotiations.
Factors Influencing Price Changes
- Regulatory Decisions: Approval of biosimilars or generics could induce price reductions.
- Market Penetration: Increased clinical adoption may lead to higher demand, supporting price stability or increases.
- Insurance Coverage: Stricter utilization management may suppress retail prices.
- Manufacturing Costs: Changes in raw material costs can impact wholesale prices.
Revenue and Market Share Forecast
Projected revenues depend on penetration rates among eligible patients and competitive pricing. Assuming a conservative 10% market share in the estimated USD [market size] for the indication, revenues could reach USD [projection] by 2025.
| Year |
Estimated Units Sold |
Revenue (USD) |
Market Share Target |
| 2023 |
[units] |
USD [amount] |
0% (launch year) |
| 2024 |
[units] |
USD [amount] |
5-10% |
| 2025 |
[units] |
USD [amount] |
10% (target) |
Key Market Risks
- Regulatory Delays: New approvals or restrictions could alter market size.
- Competitive Developments: Entry of biosimilars or generics will pressure pricing.
- Reimbursement Policies: Insurer restrictions could limit patient access, impacting revenue.
Summary
NDC 58151-0367 is positioned within a high-growth therapeutic market, facing significant competition but with potential for stable pricing. Price projections suggest marginal increases aligned with industry trends, barring disruptive market entries or regulatory changes.
Key Takeaways
- The drug’s current retail price is USD [amount]; wholesale price is USD [amount].
- Market conditions support moderate price stability through 2025.
- Competition, biosimilar entry, and reimbursement policies are primary risk factors.
- Revenue forecasts depend on market penetration; a 10% share could generate USD [amount] by 2025.
- Regulatory and manufacturing factors could influence future pricing dynamics.
FAQs
1. What are the main therapeutic indications for NDC 58151-0367?
It is approved for [specific conditions], which contribute to the growing demand.
2. How does the price compare to similar therapeutics?
It aligns with prices of comparable drugs in the same class, typically ranging from USD [lower bound] to USD [upper bound] per course.
3. What factors could lead to a price reduction?
Biosimilar or generic approval, increased market competition, and insurer negotiations can drive prices down.
4. How does coverage affect prescribing?
Insurance formulary placement influences patient access; drugs in preferred tiers tend to see higher utilization.
5. What are the long-term market prospects?
The market remains promising given rising disease prevalence, but biosimilar competition and regulatory actions could curtail growth.
References
[1] MarketWatch. (2022). Global Market for [Therapeutic Area]. Retrieved from https://www.marketwatch.com
[2] FDA. (2023). Drug Approvals and Labeling. U.S. Food & Drug Administration. https://www.fda.gov
[3] IQVIA. (2022). Market Data and Forecasts for [Indication]. IQVIA Institute. https://www.iqvia.com
